Efficacy evaluation | AS-SMP 3 days | AS-SMP 24 hours | AL 3 days | P |
---|---|---|---|---|
Age < 5 years – n | 144 | 111 | 126 | |
ACPR – n (%,95%CI) | 144 (100%,97.5–100.0) | 111 (100%,96.7–100.0) | 126 (100%,97.1–100.0) | -- |
Age >= 5 years – n | 293 | 308 | 268 | |
ACPR – n (%,95%CI) | 290 (99.0%,97.0–99.8) | 306 (99.4%,97.7–99.9) | 267 (99.6%,97.9–100.0) | 0.78 (Fisher) |